Page last updated: 2024-08-23

paclitaxel and Angiosarcoma

paclitaxel has been researched along with Angiosarcoma in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.49)	18.2507
2000's	13 (19.40)	29.6817
2010's	37 (55.22)	24.3611
2020's	16 (23.88)	2.80

Authors

Authors	Studies
Goyal, S; Kapoor, R; Khosla, D; Madan, R; Periasamy, K; Sali, AP; Singla, V	1
Kitamura, S; Seo, T; Ujiie, H; Yanagi, T	1
Inoue, Y; Ito, H; Kato, T; Oba, A; Ono, Y; Sato, T; Shigematsu, Y; Suzuki, T; Takahashi, Y; Ushida, Y	1
Bi, S; Cen, Y; Chen, J; Li, J; Yin, X; Zhong, A	1
Liu, YY; Pan, QZ; Peng, RQ; Xu, BS; Yang, QQ; Zhang, X	1
Asano, Y; Fujimura, T; Fujisawa, Y; Hashimoto, A; Ishizuki, S; Ito, T; Kambayashi, Y; Kato, H; Maekawa, T; Matsushita, S; Segawa, K; Yamamoto, J; Yoshino, K	1
Bay, JO; El-Ghazzi, N	1
Egawa, G; Endo, Y; Fujii, H; Ishikawa, M; Kabashima, K; Yonekura, S	1
Saito, Y; Umemori, Y; Yokoyama, R	1
André, F; Frischhut, N; Nguyen, VA; Schmuth, M; Skvortsov, S; Walder, A	1
Maeda, T; Nakano, E; Namikawa, K; Oashi, K; Shibata, T; Takahashi, A; Teramoto, Y; Tsutsumida, A; Yamazaki, N; Yokota, K	1
Fujisawa, Y; Hiramatsu, Y; Ieda, M; Ishizu, T; Noguchi, M; Sakamoto, N; Sekine, I; Suzuki, H; Suzuki, T; Tajiri, K; Yamamoto, Y	1
Alavi, S; Chekerov, R; Chinczewski, L; DrÖge, LA; Feldhaus, FW; Muallem, MZ; Pietzner, K; Sehouli, J; Taube, ET	1
Chan, JCH; Chang, CC; Chen, TW; Endo, M; Farid, M; Goh, WL; Hirose, T; Kawai, A; Leung, AKC; Loong, HH; Maw, MM; Mingmalairak, S; Ngan, RKC; Pang, A; Puhaindran, ME; Quek, R; Sriuranpong, V; Tan, SH	1
Keam, B; Kim, DW; Kim, M; Kim, SH; Kim, TM; Kim, YJ; Kwak, Y; Moon, KC; Park, C	1
Han, L; Li, W; Ye, Z	1
Allende, D; Fadare, O; Forscher, C; Roma, AA; Rutgers, JK	1
Baniandrés Rodriguez, O; Ciudad Blanco, C; Ruedas Martínez, A; Vilas Boas, P	1
Dabouz, F; Farhat, MM; Le Guern, A; Modiano, P; Peugniez, C; Quinchon, JF	1
Hamaguchi, Y; Kitano, T; Maeda, S; Matsumoto, I; Mizumaki, K; Oishi, K; Saito, D; Takehara, K; Yoshida, S	1
Bertucci, F; Blay, JY; Bompas, E; Camoin, L; Goncalves, A; Italiano, A; Le Cesne, A; Le Deley, MC; Lebellec, L; Mir, O; Penel, N; Ray-Coquard, I; Ryckewaert, T; Toiron, Y; Tresch-Bruneel, E	1
Campelo, V; Chagas, DC; Coelho, EG; Costa, PVL; da Silva Junior, RG; da Silva, BB; de Almeida Melo, M; de Sousa Júnior, EC; Eulálio Filho, WMN; Gebrim, LH; Junior, AMC; Neto, FM; Silva, RA; Tavares, CB	1
Fischer-Valuck, BW; Gabani, P; Michalski, JM; Robinson, CG; Wilson, DB	1
Arai, A; Hirano, S; Kinoshita, S; Konishi, E; Mitsuda, J; Mori, D; Ozawa, S; Saburi, S; Takenaka, M; Tsujikawa, T; Yoshimura, K	1
Kiyohara, T; Makimura, K; Miyamoto, M; Nagano, N; Nakamaru, S; Shijimaya, T; Tanimura, H	1
Alberghini, M; Antonescu, CR; Bertoni, F; Cesari, M; Ferrari, C; Ferrari, S; Maki, RG; Marchesi, E; Mavrogenis, A; Paioli, A; Palmerini, E; Picci, P; Ruggieri, P; Staals, EL	1
Grellety, T; Italiano, A	1
Chin, F; Farid, M; Ho, ZC; Jeevan, R; Lee, MJ; Ong, WS; Poon, D; Quek, R; Sairi, AN; Soh, LT; Teh, J; Teo, M	1
García-Silva, J; Nespereira-Jato, MV; Peña-Panabad, C; Quindós-Varela, M	1
Brown, NJ; Reed, MW; Staton, CA; Woll, PJ; Young, RJ	1
Argenyi, ZB; Choi, WT; George, E; Olerud, JE; Stetsenko, GY; Zhang, J	1
Fujimoto, M; Fujisawa, Y; Kadono, T; Miyagawa, T; Nakamura, Y; Yoshino, K	1
Bareggi, C; Blundo, C; Galassi, B; Gambini, D; Locatelli, E; Runza, L; Sosnovskikh, I; Tomirotti, M; Visintin, R	1
Aoi, J; Fukushima, S; Ihn, H; Jinnin, M; Kajihara, I; Kanemaru, H; Masuguchi, S; Miyake, T	1
Bay, JO; Bertucci, F; Blay, JY; Bompas, E; Cassier, PA; Chevreau, C; Clisant, S; Collard, O; Cupissol, D; Delcambre, C; Domont, J; Isambert, N; Italiano, A; Le Cesne, A; Mir, O; Penel, N; Piperno-Neumann, S; Ray-Coquard, IL; Saada-Bouzid, E; Tresch-Bruneel, E	1
Amaya, CN; Bryan, BA; Chow, M; Chow, W; Dickerson, EB; Rains, S	1
Dieckmann, C; Eich, HT; Elsayad, K; Haverkamp, U; Kriz, J; Lehrich, P; Yppaerilae-Wolters, H	1
Dougherty, M; Loiselle, A; Munzer, K; Patel, MB; Williams, P	1
Darr-Foit, S; Elsner, P; Goetze, S	1
Arndt, CA; Good, AB; Nascimento, A; Welker, KM	1
Blay, JY; Hartmann, JT; Hogendoorn, PC; Judson, I; Marreaud, S; Reichardt, P; Schlemmer, M; Thyss, A; Van Glabbeke, M; Verweij, J	1
Bay, JO; Blay, JY; Bompas, E; Brain, EG; Bui, BN; Chevreau, C; Cupissol, D; Fournier, C; Isambert, N; Jimenez, M; Kerbrat, P; Penel, N; Peyrade, F; Piperno-Neumann, S; Ray-Coquard, I; Taieb, S	1
Gagnon, PJ; Galderisi, C; Holland, JM; Page, BR	1
Becker, JC; Bröcker, EB; Hofmann, UB; Kleine, P; Kneitz, H; Ugurel, S; Wobser, M	1
Marquez, A; Perez-Ruiz, E; Ribelles, N; Roman, A; Sanchez-Muñoz, A	1
Aguirre, E; Castilla, E; Del Río, A; Pascual, I; Roncalés, F	1
Cozzio, A; Donghi, D; Dummer, R	1
Charlson, JA; Dankle, SK; Fuller, CK; Russell, TJ	1
Bhagwandas, K; Kamath, S	1
Bay, JO; Bertucci, F; Blay, JY; Bompas, E; Bui, B; Chaigneau, L; Cupissol, D; Delcambre, C; Duffaud, F; Guillemet, C; Isambert, N; Italiano, A; Penel, N; Ray-Coquard, I; Robin, YM	1
Fujita, S; Hata, A; Imai, Y; Katakami, N; Kokubo, M	1
Bordeaux, JS; Honda, KS; Robinson, MR	1
Jiang, PY; Kantorowitz, D; Yanke, R	1
Bakhshi, S; Ram Prabu, MP; Ray, R; Thulkar, S	1
Antonescu, C; Bertucci, F; Blay, JY; Bui, B; Chevreau, C; Cioffi, A; D'Adamo, DR; Delcambre, C; Isambert, N; Italiano, A; Kalbacher, E; Keohan, ML; Levra, MG; Maki, RG; Penel, N	1
Henderson, M; Hui, A; Skandarajah, A; Speakman, D	1
Hoffmann, G; Mylonas, I	1
Backes, M; Bode-Erdmann, S; Greulich, S; Hebart, H; Kaufmann, M; Mahrholdt, H; Ong, P; Ott, G; Schumm, J	1
Brasky, J; Ehrenpreis, ED; Shah, DA; Sherid, M; Sifuentes, H	1
Paredes-Suarez, C; Pestoni, C; Peteiro, C; Toribio, J	1
Haddad, PA; Skubitz, KM	1
Deutsch, M; Werner, R	1
Mathew, P; Troncoso, P; Vakar-Lopez, F	1
Keeling, IM; Ploner, F; Rigler, B	1
Adenis, A; Lansiaux, A; Penel, N	1
Hiroshima, K; Kasahara, Y; Kuriyama, T; Kurosu, K; Sakao, S; Shinozaki, A; Tada, Y; Takiguchi, Y; Tanabe, N; Tatsumi, K; Terada, J; Yoshida, T	1
Casper, ES; Fata, F; Ilson, D; Kelsen, DP; Leffel, D; O'Reilly, E; Pfister, D; Schwartz, GK	1

Reviews

6 review(s) available for paclitaxel and Angiosarcoma

Article	Year
Management of Cutaneous Angiosarcoma: an Update Review. Current treatment options in oncology, 2022, Volume: 23, Issue:2 Topics: Chemoradiotherapy; Hemangiosarcoma; Humans; Neoadjuvant Therapy; Paclitaxel; Skin Neoplasms	2022
First sonographic description of idiopathic Cutaneous Angiosarcoma of the Head and Neck. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:10 Topics: Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biopsy; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Paclitaxel; Skin Neoplasms; Ultrasonography, Doppler, Color	2017
Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature. Tumori, 2015, Apr-28, Volume: 101, Issue:2 Topics: Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Administration Schedule; Female; Hemangiosarcoma; Humans; Induction Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome	2015
Clinical and endoscopic features of angiosarcoma of the colon: two case reports and a review of the literature. Journal of gastrointestinal cancer, 2013, Volume: 44, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Colonic Neoplasms; Endoscopy, Digestive System; Female; Gastrointestinal Hemorrhage; Hemangiosarcoma; Humans; Imatinib Mesylate; Paclitaxel; Piperazines; Pyrimidines; Review Literature as Topic; Treatment Outcome	2013
Angiosarcoma of the breast with delay in diagnosis. Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:5 Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Early Diagnosis; False Negative Reactions; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Radiotherapy, Adjuvant; Telangiectasis	2004
Angiosarcomas and taxanes. Current treatment options in oncology, 2007, Volume: 8, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Doxorubicin; Hemangiosarcoma; Humans; Paclitaxel; Radiotherapy, Adjuvant; Taxoids	2007

Trials

4 trial(s) available for paclitaxel and Angiosarcoma

Article	Year
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial. BMC cancer, 2018, Oct-11, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Bevacizumab; Biomarkers, Tumor; Female; Hemangiosarcoma; Humans; Middle Aged; Paclitaxel; Placenta Growth Factor; Prognosis; Vascular Endothelial Growth Factor A	2018
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Sep-01, Volume: 33, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Skin Neoplasms; Treatment Outcome	2015
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Nov-10, Volume: 26, Issue:32 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; France; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Scalp; Skin Neoplasms; Soft Tissue Neoplasms; Time Factors; Treatment Outcome	2008
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer, 1999, Nov-15, Volume: 86, Issue:10 Topics: Aged; Antineoplastic Agents, Phytogenic; Facial Neoplasms; Female; Hemangiosarcoma; Humans; Male; Middle Aged; Paclitaxel; Scalp; Skin Neoplasms	1999

Other Studies

57 other study(ies) available for paclitaxel and Angiosarcoma

Article	Year
Primary angiosarcoma of the seminal vesicle. Andrologia, 2022, Volume: 54, Issue:3 Topics: Adult; Combined Modality Therapy; Endothelial Cells; Hemangiosarcoma; Humans; Male; Paclitaxel; Seminal Vesicles	2022
Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 cases. The Journal of dermatology, 2022, Volume: 49, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Hemangiosarcoma; Humans; Paclitaxel; Prospective Studies; Retrospective Studies; Skin Neoplasms	2022
Conversion surgery for recurrent hepatic angiosarcoma after systemic chemotherapy with paclitaxel. Clinical journal of gastroenterology, 2022, Volume: 15, Issue:2 Topics: Aged; Hemangiosarcoma; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Paclitaxel	2022
[Single-center study of different treatment for advanced or unresectable angiosarcoma patients]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2023, Jan-23, Volume: 45, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Hemangiosarcoma; Humans; Male; Paclitaxel; Retrospective Studies	2023
Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases. The Journal of dermatology, 2023, Volume: 50, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; East Asian People; Female; Hemangiosarcoma; Humans; Paclitaxel; Retrospective Studies; Skin Neoplasms; Taxoids	2023
[Rare tumors: Angiosarcoma]. Bulletin du cancer, 2023, Volume: 110, Issue:5 Topics: Breast Neoplasms; Female; Hemangiosarcoma; Humans; Paclitaxel; Prognosis; Sarcoma	2023
Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy. The Journal of dermatology, 2023, Volume: 50, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Hemangiosarcoma; Humans; Paclitaxel; Skin Neoplasms; Taxoids	2023
Cutaneous angiosarcoma: Efficacy and treatment regimen of paclitaxel maintenance therapy. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Hemangiosarcoma; Humans; Paclitaxel; Skin Neoplasms	2020
Combined nab-paclitaxel and irradiation for large cutaneous angiosarcoma of the face and scalp with pulmonary metastases. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020, Volume: 18, Issue:7 Topics: Aged; Albumins; Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Remission Induction; Scalp; Skin Neoplasms	2020
A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol). BMC cancer, 2020, Jul-13, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Indazoles; Male; Middle Aged; Paclitaxel; Prognosis; Pyrimidines; Research Design; Salvage Therapy; Skin Neoplasms; Sulfonamides; Young Adult	2020
Dramatic Recovery from Cardiovascular Collapse: Paclitaxel as an Urgent Treatment for Primary Cardiac Angiosarcoma. Internal medicine (Tokyo, Japan), 2021, Jan-01, Volume: 60, Issue:1 Topics: Heart Neoplasms; Hemangiosarcoma; Humans; Paclitaxel; Shock	2021
Angiosarcomas of Primary Gynecologic Origin - A Case Series and Review of the Literature. Anticancer research, 2020, Volume: 40, Issue:10 Topics: Adult; Aged; Combined Modality Therapy; Drug Therapy; Female; Genital Neoplasms, Female; Hemangiosarcoma; Humans; Laparotomy; Middle Aged; Neoplasm Metastasis; Paclitaxel	2020
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium. Cancer science, 2021, Volume: 112, Issue:3 Topics: Academic Medical Centers; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asia; Doxorubicin; Female; Hemangiosarcoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Polyethylene Glycols; Prognosis; Progression-Free Survival; Retrospective Studies; Risk Factors; Skin Neoplasms; Young Adult	2021
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment. Cancer research and treatment, 2021, Volume: 53, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Indazoles; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Pyrimidines; Retrospective Studies; Skin Neoplasms; Sulfonamides; Survival Rate	2021
Primary pericardial angiosarcoma: A case report. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5 Topics: Adult; Doxorubicin; Heart Neoplasms; Hemangiosarcoma; Humans; Male; Mediastinal Neoplasms; Paclitaxel; Pericardium; Thymus Neoplasms; Young Adult	2022
On Uterine Angiosarcomas: 2 Additional Cases. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2017, Volume: 36, Issue:4 Topics: Antineoplastic Agents; Carboplatin; Disease-Free Survival; Docetaxel; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Paclitaxel; Uterine Neoplasms; Uterus	2017
[Angiosarcoma in primary lymphoedema: A rare complication]. Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:4 Topics: Aged; Antineoplastic Agents, Phytogenic; Chronic Disease; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lower Extremity; Lymphedema; Paclitaxel; Skin Neoplasms	2018
Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432. European journal of dermatology : EJD, 2018, Aug-01, Volume: 28, Issue:4 Topics: Aged; Antineoplastic Agents; Fatal Outcome; Hemangiosarcoma; Hemothorax; Humans; Male; Paclitaxel; Picibanil; Pleural Neoplasms; Pleurodesis; Pneumothorax; Recurrence; Skin Neoplasms	2018
A rare case of primary breast angiosarcoma in a male: a case report. BMC cancer, 2018, Oct-16, Volume: 18, Issue:1 Topics: Adult; Brain Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Hemangiosarcoma; Humans; Male; Paclitaxel	2018
Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability. Practical radiation oncology, 2019, Volume: 9, Issue:1 Topics: Adolescent; Female; Heart Neoplasms; Hemangiosarcoma; Hemodynamics; Humans; Paclitaxel; Radiosurgery	2019
Radiation-induced angiosarcoma of the parotid gland after postoperative radiotherapy for hypopharyngeal carcinoma. Auris, nasus, larynx, 2019, Volume: 46, Issue:6 Topics: Antineoplastic Agents; Brain Neoplasms; Diagnosis, Differential; Female; Hemangiosarcoma; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Parotid Neoplasms; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck	2019
Radiation-associated angiosarcoma with histological features reminiscent of Kaposi's sarcoma successfully treated by radiotherapy with paclitaxel. The Journal of dermatology, 2019, Volume: 46, Issue:10 Topics: Aged, 80 and over; Breast; Breast Neoplasms; Chemoradiotherapy; Diagnosis, Differential; Dose Fractionation, Radiation; Female; Hemangiosarcoma; Humans; Mastectomy, Segmental; Neoplasms, Radiation-Induced; Paclitaxel; Radiotherapy, Adjuvant; Sarcoma, Kaposi; Skin; Treatment Outcome	2019
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions. American journal of clinical oncology, 2014, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Female; Femoral Neoplasms; Femur; Hemangiosarcoma; Humans; Humerus; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pelvic Bones; Radiotherapy; Radiotherapy, Adjuvant; Radius; Retrospective Studies; Skull Neoplasms; Spinal Neoplasms; Treatment Outcome; Ulna; Young Adult	2014
Angiosarcoma associated with a Kasabach-Merritt syndrome: report of two cases treated with paclitaxel. Future oncology (London, England), 2013, Volume: 9, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Female; Hemangiosarcoma; Humans; Kasabach-Merritt Syndrome; Male; Paclitaxel; Prognosis	2013
Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre. Oncology, 2013, Volume: 85, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Male; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Scalp; Singapore; Skin Neoplasms; Survival Analysis; Treatment Outcome	2013
Unresectable angiosarcoma treated with bevacizumab and paclitaxel. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:5 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Paclitaxel; Remission Induction; Scalp; Skin Neoplasms	2014
Vascular-targeted agents for the treatment of angiosarcoma. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:2 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Axitinib; Bevacizumab; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Movement; Doxorubicin; Everolimus; Hemangiosarcoma; Humans; Imidazoles; Indazoles; Neovascularization, Pathologic; Paclitaxel; Protein Array Analysis; Sirolimus; Vascular Endothelial Growth Factor A	2014
Cutaneous angiosarcoma clinically presenting as progressive solid facial edema in a 43-year-old male. Dermatology online journal, 2013, Nov-15, Volume: 19, Issue:11 Topics: Adult; Antineoplastic Agents, Phytogenic; Edema; Facial Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Paclitaxel; Skin Neoplasms; Spinal Neoplasms; Thoracic Vertebrae	2013
Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study. The British journal of dermatology, 2014, Volume: 171, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Chemoradiotherapy; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Scalp; Skin Neoplasms; Taxoids; Treatment Outcome	2014
Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel. Drug discoveries & therapeutics, 2015, Volume: 9, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Female; Hemangiosarcoma; Humans; Oxonic Acid; Paclitaxel; Skin Neoplasms; Taxoids; Tegafur	2015
Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade. JAMA dermatology, 2015, Volume: 151, Issue:11 Topics: Adrenergic beta-Antagonists; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Face; Hemangiosarcoma; Humans; Male; Middle Aged; Paclitaxel; Propranolol; Scalp; Skin Neoplasms; Treatment Outcome	2015
Primary Cardiac Angiosarcoma Treated With Positron Emission Tomography/Magnetic Resonance Imaging-Guided Adaptive Radiotherapy. The Canadian journal of cardiology, 2016, Volume: 32, Issue:6 Topics: Adult; Antineoplastic Agents; Chemoradiotherapy; Female; Heart Neoplasms; Hemangiosarcoma; Humans; Magnetic Resonance Imaging; Paclitaxel; Positron-Emission Tomography; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Treatment Outcome	2016
Pleural Myiasis Associated With Pleural Angiosarcoma. Chest, 2016, Volume: 149, Issue:6 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Disease Management; Empyema, Pleural; Hemangiosarcoma; Humans; Hydropneumothorax; Male; Myiasis; Paclitaxel; Pleural Cavity; Pleural Neoplasms; Thoracic Surgery, Video-Assisted; Thoracostomy	2016
Fulminant course of angiosarcoma of the scalp on multimodal therapy with paclitaxel, bevacizumab, and radiation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017, Volume: 15, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Bevacizumab; Combined Modality Therapy; Facial Neoplasms; Hemangiosarcoma; Humans; Paclitaxel; Scalp	2017
Congenital angiosarcoma with transient response to paclitaxel. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Diagnosis, Differential; Fatal Outcome; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Immunohistochemistry; Infant; Lymphangioma, Cystic; Paclitaxel	2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:16 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Facial Neoplasms; Female; Hemangiosarcoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Scalp; Skin Neoplasms; Soft Tissue Neoplasms; Young Adult	2008
Angiosarcoma developing after curative induction chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the larynx. Head & neck, 2009, Volume: 31, Issue:6 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Squamous Cell; Follow-Up Studies; Hemangiosarcoma; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Radiotherapy, High-Energy; Remission Induction; Risk Assessment; Skin Neoplasms; Treatment Outcome	2009
Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalp. The British journal of dermatology, 2009, Volume: 160, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Facial Neoplasms; Forehead; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Paclitaxel; Scalp; Treatment Outcome	2009
Response to paclitaxel in a radiotherapy-induced breast angiosarcoma. Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Hemangiosarcoma; Humans; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Treatment Outcome	2009
Transient response of cardiac angiosarcoma to paclitaxel. European journal of cancer care, 2010, Volume: 19, Issue:5 Topics: Adult; Antineoplastic Agents, Phytogenic; Fatal Outcome; Heart Neoplasms; Hemangiosarcoma; Humans; Male; Paclitaxel; Treatment Outcome	2010
Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib. The British journal of dermatology, 2010, Volume: 162, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Niacinamide; Paclitaxel; Phenylurea Compounds; Pyridines; Remission Induction; Skin Neoplasms; Sorafenib; Treatment Outcome	2010
Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:4 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Follow-Up Studies; Hemangiosarcoma; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Treatment Outcome	2010
A case of epithelioid angiosarcoma of the scalp treated with paclitaxel and radiotherapy. Archives of dermatology, 2011, Volume: 147, Issue:1 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Follow-Up Studies; Hemangiosarcoma; Humans; Inflammation; Lymecycline; Male; Paclitaxel; Scalp; Skin Neoplasms	2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Doxorubicin; Female; Hemangiosarcoma; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult	2012
Angiosarcoma arising from right atrium: remarkable response to concurrent chemoradiotherapy with carboplatin and paclitaxel. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Heart Atria; Heart Neoplasms; Hemangiosarcoma; Humans; Male; Paclitaxel; Treatment Outcome	2011
Angiosarcoma in an obese woman with worsening lymphedema after weight-loss and skin-reduction surgeries. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2 Topics: Dermatologic Surgical Procedures; Disease Progression; Fatal Outcome; Female; Gastric Bypass; Hemangiosarcoma; Humans; Lower Extremity; Lymphedema; Middle Aged; Obesity, Morbid; Paclitaxel; Plastic Surgery Procedures; Skin Neoplasms; Weight Loss	2011
A novel effective therapy for refractory angiosarcoma of the face and scalp. Clinical advances in hematology & oncology : H&O, 2011, Volume: 9, Issue:6 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Deoxycytidine; Doxorubicin; Face; Female; Gemcitabine; Hemangiosarcoma; Humans; Methotrexate; Paclitaxel; Radiotherapy; Salvage Therapy; Scalp; Skin Neoplasms	2011
Primary cardiac angiosarcoma with good response to Paclitaxel. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Heart Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome	2011
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer, 2012, Jul-01, Volume: 118, Issue:13 Topics: Aged; Antineoplastic Agents; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Male; Paclitaxel; Prognosis; Retrospective Studies; Skin Neoplasms	2012
Angiosarcoma of the breast: a difficult surgical challenge. Breast (Edinburgh, Scotland), 2012, Volume: 21, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome	2012
Therapy of radiation-induced angiosarcoma of the breast in an elderly patient. Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:4 Topics: Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Female; Hemangiosarcoma; Humans; Hyperthermia, Induced; Neoplasms, Radiation-Induced; Paclitaxel	2013
Favorable course of pericardial angiosarcoma under paclitaxel followed by pazopanib treatment documented by cardiovascular magnetic resonance imaging. Circulation, 2012, Oct-30, Volume: 126, Issue:18 Topics: Adrenal Cortex Hormones; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Delayed Diagnosis; Diagnostic Errors; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Indazoles; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Myocardium; Paclitaxel; Pericardial Effusion; Pericardiocentesis; Pericarditis; Pericardium; Protein Kinase Inhibitors; Pulmonary Embolism; Pyrimidines; Remission Induction; Sulfonamides; Vincristine	2012
Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Facial Neoplasms; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Paclitaxel; Scalp; Skin Neoplasms	2005
Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer, 2005, Jul-15, Volume: 104, Issue:2 Topics: Aged; Antineoplastic Agents; Doxorubicin; Hemangiosarcoma; Humans; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Treatment Outcome	2005
Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin. The Lancet. Oncology, 2006, Volume: 7, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Doxorubicin; Hemangiosarcoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Testicular Neoplasms; Treatment Outcome	2006
Familial cardiac angiosarcoma. The Annals of thoracic surgery, 2006, Volume: 82, Issue:4 Topics: Adult; Antineoplastic Agents; Cardiac Surgical Procedures; Fatal Outcome; Heart Neoplasms; Heart Transplantation; Hemangiosarcoma; Humans; Male; Paclitaxel	2006
[A case of angiosarcoma of pelvis with pulmonary metastases which responded to paclitaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:13 Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pelvic Bones; Salvage Therapy	2007